Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SPPL3 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA563803
Description
Immunogen sequence: VLRYDNYKKQ ASGDSCGAPG PANISGRMQK VSY Highest antigen sequence identity to the following orthologs: Mouse - 100%, Rat - 97%.
Signal peptide peptidase (SPP) is an aspartyl protease that mediates clearance of signal peptides by proteolysis within the endoplasmic reticulum (ER). Like presenilins, SPP contains a critical GXGD motif in its C-terminal catalytic center. SPPL3 is one of several presenilin homologues/SPP-like proteins (PSHs/SPPL) that have been identified.
Specifications
SPPL3 | |
Polyclonal | |
Unconjugated | |
SPPL3 | |
4833416I09Rik; fb94d08; Imp2; IMP-2; Intramembrane protease 2; MDHV1887; Presenilin homologous protein 1; presenilin-like protein 4; PRO4332; PSH1; PSL4; putative intramembrane aspartyl protease; RGD1562826; signal peptide peptidase 3; signal peptide peptidase like 3; signal peptide peptidase-like 3; signal peptide peptidase-like 3, pseudogene 1; Signal peptide peptidase-like 3-like protein; signal peptide peptidase-like protein 3; Sppl3; sppl3 protein; Sppl3-ps1; SPP-like 3; SPP-like 3 protein; upregulated during skeletal muscle growth 3; Usmg3; wu:fb94d08; zgc:114093 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
121665 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q8TCT6 | |
SPPL3 | |
Recombinant protein corresponding to Human SPPL3. Recombinant protein control fragment (Product #RP-101387). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction